;Also provided is a composition comprising the any of the fusion proteins of this invention and a pharmaceutically acceptable carrier, a method of treating a subject suffering from age-related macular degeneration (AMD), diabetic retinopathy, or cancer which comprises administering to the subject any of the compositions of this invention in an amount effective to treat the subject's cancer."/>
公开/公告号US11026996B2
专利类型
公开/公告日2021-06-08
原文格式PDF
申请/专利号US201716304595
申请日2017-05-25
分类号C07K14/705;C07K16/28;C07K19;A61K38/17;A61K39/395;A61K38/18;A61P35;A61P27/02;A61K45/06;C12N15/62;C12N15/85;
国家 US
入库时间 2022-08-24 19:06:11